CD8A and neoplasm: Melatonin’s canonical clock-gene targets (BMAL1, PER2) intersect with T-cell metabolic checkpoints, restoring rhythmic oxidative phosphorylation and IL-2 responsiveness in tumour-infiltrating CD8+ cells (53).